220 related articles for article (PubMed ID: 22682934)
1. Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma.
Won HS; Jung CK; Chun SH; Kang JH; Kim YS; Sun DI; Kim MS
Oral Oncol; 2012 Oct; 48(10):985-990. PubMed ID: 22682934
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
Horn D; Freudlsperger C; Holzinger D; Kunzmann K; Plinkert P; Dyckhoff G; Hoffmann J; Freier K; Hess J
Head Neck; 2017 Dec; 39(12):2397-2405. PubMed ID: 28945300
[TBL] [Abstract][Full Text] [Related]
3. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
Chun SH; Jung CK; Won HS; Kang JH; Kim YS; Kim MS
Head Neck; 2015 May; 37(5):636-43. PubMed ID: 24616007
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of EGFR-PI3K-pAKT-mTOR-pS6 pathway in sinonasal squamous cell carcinomas.
Muñoz-Cordero MG; López F; García-Inclán C; López-Hernández A; Potes-Ares S; Fernández-Vañes L; Llorente JL; Hermsen M
Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(1):16-24. PubMed ID: 29573781
[TBL] [Abstract][Full Text] [Related]
6. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
[TBL] [Abstract][Full Text] [Related]
7. EGFR/PI3K/Akt/mTOR pathway in head and neck squamous cell carcinoma patients with different HPV status.
Janecka-Widła A; Majchrzyk K; Mucha-Małecka A; Biesaga B
Pol J Pathol; 2021; 72(4):296-314. PubMed ID: 35142162
[TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Cortelazzi B; Verderio P; Ciniselli CM; Pizzamiglio S; Bossi P; Gloghini A; Gualeni AV; Volpi CC; Locati L; Pierotti MA; Licitra L; Pilotti S; Perrone F
J Oral Pathol Med; 2015 Oct; 44(9):734-45. PubMed ID: 25495427
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of pAKT/PTEN expression in oral squamous cell carcinoma treated with cetuximab-based chemotherapy.
Lyu J; Song H; Tian Z; Miao Y; Ren G; Guo W
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jan; 121(1):67-72. PubMed ID: 26577500
[TBL] [Abstract][Full Text] [Related]
10. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
[TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.
Bumrungthai S; Munjal K; Nandekar S; Cooper K; Ekalaksananan T; Pientong C; Evans MF
J Transl Med; 2015 Jul; 13():244. PubMed ID: 26209091
[TBL] [Abstract][Full Text] [Related]
15. ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.
Wang J; Zhang C; Chen K; Tang H; Tang J; Song C; Xie X
Breast Cancer Res Treat; 2015 Jul; 152(2):255-69. PubMed ID: 26070269
[TBL] [Abstract][Full Text] [Related]
16. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
[TBL] [Abstract][Full Text] [Related]
17. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas.
Stankiewicz E; Prowse DM; Ng M; Cuzick J; Mesher D; Hiscock F; Lu YJ; Watkin N; Corbishley C; Lam W; Berney DM
PLoS One; 2011 Mar; 6(3):e17517. PubMed ID: 21407808
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
Chiosea SI; Grandis JR; Lui VW; Diergaarde B; Maxwell JH; Ferris RL; Kim SW; Luvison A; Miller M; Nikiforova MN
BMC Cancer; 2013 Dec; 13():602. PubMed ID: 24341335
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
[TBL] [Abstract][Full Text] [Related]
20. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]